Atopic Dermatitis Linked to Autoimmune Diseases
Autoimmune disease comorbidity among adults with atopic dermatitis is common.
Autoimmune disease comorbidity among adults with atopic dermatitis is common.
Researchers quantified the risk for death among patients with rare autoimmune rheumatic diseases vs the general population during the COVID-19 pandemic.
Study authors reviewed the evidence on the effectiveness of low-dose aspirin in the primary prevention of cardiovascular disease in systemic autoimmune rheumatic diseases.
Researchers described patients with autoimmune inflammatory rheumatic diseases with COVID-19 and the risk factors associated with hospitalization related to COVID-19.
Researchers evaluated the possibility of SARS-CoV-2 infection accelerating the onset of an autoimmune rheumatic disease.
Researchers evaluated the prevalence of hospital-diagnosed COVID-19 in chronic inflammatory and autoimmune rheumatic diseases.
In this Q&A, Maximilian Konig, MD, provides further insight into the overall effect of COVID-19 on patients with autoimmune diseases.
Study leads Shilpa Venkatachalam, PhD, and Michael George, MD, discuss the highlights of a new initiative to track the effects of COVID-19 in autoimmune disorders.
Trimethoprim-sulfamethoxazole (TMP-SMX) for Pneumocystis jirovecii pneumonia (PCP) prophylaxis in combination with methotrexate (MTX) was shown to be successful and well-tolerated in patients with chronic inflammatory/autoimmune diseases.
Researchers examined the association between maternal autoimmune disorders and the risk for Kawasaki disease in offspring.